IDOSE TR

travoprost intracameral · Glaukos Corporation

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IDOSE TR, covering 2023-12-13 to 2026-01-27. Get the full timeline:

Most recent: FDA Approved: IDOSE TR — Supplemental Application (Glaukos Corporation)